CrystalGenomics Inc. | Ownership
Companies that own CrystalGenomics Inc.
The Vanguard Group, Inc.
763,329
1.93%
6,461
0%
07/31/2018
BlackRock Fund Advisors
349,465
0.88%
0
0%
09/05/2018
Baillie Gifford & Co.
91,628
0.23%
0
0%
10/31/2017
Norges Bank Investment Management
82,926
0.21%
61,719
0%
12/31/2017
BlackRock Advisors (UK) Ltd.
78,520
0.2%
0
0%
09/05/2018
Mirae Asset Global Investments Co., Ltd.
64,670
0.16%
17,055
0.01%
04/30/2018
Charles Schwab Investment Management, Inc.
30,568
0.08%
0
0%
09/06/2018
SSgA Funds Management, Inc.
18,781
0.05%
0
0%
09/06/2018
TIAA-CREF Investment Management LLC
16,432
0.04%
0
0%
03/31/2018
Cornerstone Advisors, Inc. (Washington)
4,096
0.01%
0
0.01%
07/31/2018
| Address |
5/F, Tower A, Korea Bio Park
Seongnam GY 13488
Korea, Republic Of
|
|
Employees
|
- |
| Website |
http://www.crystalgenomics.com |
| Updated |
09/14/2018 |
| CrystalGenomics, Inc. engages in the discovery and development of novel therapeutics. The company operates through following business divisions: Research and Development, New Drug Development division, New Drug Sales, Products Sales, and Real Estate Leasing. The Research and Development division provides analysis of clinical trials services. |
